Definitive Contract HT942726CE027
Award Date 7/1/26
Potential Completion Date 10/31/28
Potential Value $1.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lowell, MA 01852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency has awarded a $249,969 Small Business Innovation Research (SBIR) Phase I contract to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company, for the development of an integrated multiplexed low-cost diagnostic platform for rapid microbial identification. This total small business set-aside contract, designated as a purchase order with firm fixed price terms, represents the initial phase of research and development aimed at advancing medical...
- The Defense Health Agency awarded a Phase II Small Business Innovation Research (SBIR) contract valued at approximately $1.3 million to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company. This total small business set-aside contract, designated as a Definitive Contract with firm fixed pricing, supports the development of a rapid, automated, multiplexed omics platform. The contract was awarded on September 26, 2025, with an ultimate completion date of January 25, 2028....
- <p>The Defense Health Agency issued a purchase order to Emergingdx Inc. on October 9, 2024, for a Small Business total set-aside SBIR Phase 1 effort valued at $249,993.61, with ultimate completion by May 8, 2025. The order procures development of a rapid, automated, multiplexed omics platform for medical research and development applications. Work is performed in Mansfield, Massachusetts.</p>
- <p>The Defense Health Agency awarded a purchase order to Emergingdx Inc. for $249,998.68 on February 11, 2024, under a Total Small Business set-aside for a multiplexed diagnostic platform for invasive fungal infection (SBIR Phase I). Work is performed in Mansfield, Massachusetts. The ultimate completion date is September 11, 2024. The contract carries firm fixed price pricing.</p>
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
- The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
- The Defense Health Agency (DHA) awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, an Other Transaction Agreement valued at $11.2M for the provision of rapid human diagnostics gastrointestinal and respiratory panels. The contract, awarded on October 8, 2024, has an ultimate completion date of April 7, 2028, and will be performed at Cepheid's Sunnyvale facility. This procurement supports DHA's clinical laboratory operations and infectious disease testing...
- Biomerieux Inc. was awarded a firm fixed price blanket purchase agreement call against an unspecified multiple award contract vehicle by the Defense Health Agency. The contract is valued at twenty-four thousand dollars to provide microbial identification strips and perform epsilometer tests. Work will be performed in Bethesda, Maryland through March 15, 2022 to support the Defense Health Agency's medical product testing and evaluation programs. No set aside provisions or subcontractors were...
- <p>The Defense Health Agency issued a $39,051 delivery order to Rapid Micro Biosystems, Inc. on February 9, 2026, for quarterly deliveries of consumables supporting the Growth Direct System owned by the Pilot Bioproduction Facility.</p> <p>Place of performance is Lowell, MA. The order is firm fixed price with an ultimate completion date of December 31, 2026. No set-aside applies to this order.</p>
- The Defense Health Agency awarded a $1.299 million definitive contract to Godx Inc., a minority-owned small disadvantaged business, for rapid identification of pathogens from water and wastewater on September 15, 2025, under a total small business set-aside. The contract is firm fixed price with an ultimate completion date of January 14, 2028. Place of performance is Madison, Wisconsin. The originating solicitation addresses rapid pathogen detection capabilities to support military force...